Xenon Pharmaceuticals Market Sentiment

Xenon Pharmaceuticals Inc

XENENASDAQ

$37.62

0.210.56%

Últ. Act.: Nov 2, 4:00 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 6 días de ahora en lun nov 9th, después del cierre del mercado

Xenon Pharmaceuticals Market Sentiment

Market sentiment signals for Xenon Pharmaceuticals (XENE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.6% short float

Options Flow▲ 0.16 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

0.16

More calls — Bullish

108 calls · 17 puts

Avg Consensus PT

$62

+64.5%

Highest Price Target

$90

+139.2%

Baird

Lowest Price Target

$46

+22.3%

Deutsche Bank

Short Interest

7.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 6, 2026	Guggenheim	Delma Caiati—	+94.0%	$73	Assumes	Buy
Sep 18, 2026	RBC Capital	Brian Abrahams—	+86.1%	$81 → $70	Maintained	Outperform
Sep 18, 2026	Wedbush	Laura Chico—	+46.2%	$71 → $55	Maintained	Outperform
Sep 18, 2026	Wells Fargo	Benjamin Burnett—	+70.1%	$69 → $64	Maintained	Overweight
Sep 18, 2026	Deutsche Bank	David Hoang—	+22.3%	$90 → $46	Downgrade	Buy→Hold
Sep 18, 2026	Needham	Serge Belanger—	+59.5%	$78 → $60	Maintained	Buy
Sep 18, 2026	Baird	Brian Skorney—	+139.2%	$97 → $90	Maintained	Outperform
Aug 7, 2026	RBC Capital	Brian Abrahams—	+115.3%	$82 → $81	Maintained	Outperform
May 27, 2026	JP Morgan	Tessa Romero—	+118.0%	$80 → $82	Maintained	Overweight
May 12, 2026	JP Morgan	Tessa Romero—	+112.7%	$77 → $80	Maintained	Overweight
May 8, 2026	RBC Capital	Brian Abrahams—	+118.0%	$80 → $82	Maintained	Outperform
May 8, 2026	Needham	Serge Belanger—	+107.3%	$80 → $78	Maintained	Buy
Mar 16, 2026	Wedbush	Laura Chico—	+67.5%	$64 → $63	Maintained	Outperform
Mar 10, 2026	Wells Fargo	Benjamin Burnett—	+80.8%	$49 → $68	Maintained	Overweight
Mar 10, 2026	Wedbush	Laura Chico—	+70.1%	$47 → $64	Maintained	Outperform
Mar 10, 2026	Deutsche Bank	David Hoang—	+139.2%	$56 → $90	Maintained	Buy
Mar 10, 2026	HC Wainwright & Co.	Douglas Tsao—	+96.7%	$53 → $74	Maintained	Buy
Mar 9, 2026	Needham	Serge Belanger—	+112.7%	$58 → $80	Maintained	Buy
Mar 9, 2026	Baird	Brian Skorney—	+157.8%	$63 → $97	Maintained	Outperform
Feb 27, 2026	Needham	Serge Belanger—	+54.2%	$55 → $58	Maintained	Buy
Feb 27, 2026	Wells Fargo	Benjamin Burnett—	+30.2%	$48 → $49	Maintained	Overweight
Feb 24, 2026	Wolfe Research	Rudy Li—	+59.5%	$60	Initiate	Outperform
Jan 9, 2026	JP Morgan	Tessa Romero—	+64.8%	$60 → $62	Maintained	Overweight
Dec 11, 2025	Wells Fargo	Benjamin Burnett—	+27.6%	$44 → $48	Maintained	Overweight
Nov 18, 2025	JP Morgan	Tessa Romero—	+59.5%	$57 → $60	Maintained	Overweight